We read with great interest the recent article by Rostoker et al. [1] evaluating the cost-effectiveness of daily home haemodialysis compared with conventional in-centre haemodialysis using real-world data from the French healthcare system. The authors should be commended for addressing a clinically and economically significant issue in contemporary nephrology practice. End-stage kidney disease continues to impose a substantial and growing burden on healthcare systems worldwide, with maintenance dialysis representing one of the most resource-intensive long-term therapies encountered in chronic disease management.
